2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy-Reference-Cited by-同舟云学术

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy

Published:2018-02-09 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Maayah Zaid H.,Levasseur Jody,Siva Piragasam Ramanaguru,Abdelhamid Ghada,Dyck Jason R. B.,Fahlman Richard P.,Siraki Arno G.,El-Kadi Ayman O. S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-20613-9.pdf

Reference65 articles.

1. Maayah, Z. H. & El-Kadi, A. O. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy. Archives of toxicology 90, 119–136, https://doi.org/10.1007/s00204-015-1620-8 (2016).

2. Korashy, H. M. & El-Kadi, A. O. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug metabolism reviews 38, 411–450, https://doi.org/10.1080/03602530600632063 (2006).

3. Malik, K. U. et al. Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents. Prostaglandins & other lipid mediators 98, 69–74, https://doi.org/10.1016/j.prostaglandins.2011.12.003 (2012).

4. Maayah, Z. H. & El-Kadi, A. O. 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-kappaB-dependent mechanism. Archives of toxicology 90, 359–373, https://doi.org/10.1007/s00204-014-1419-z (2016).

5. Morgan, E. T. Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug metabolism and disposition: the biological fate of chemicals 29, 207–212 (2001).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in cardiovascular arachidonic acid metabolism in experimental models of menopause and implications on postmenopausal cardiac hypertrophy;Prostaglandins & Other Lipid Mediators;2024-08

2. Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity;Molecular Biology Reports;2024-07-27

3. Modulation of Angiotensin II–Induced Cellular Hypertrophy by Cannflavin-C: Unveiling the Impact on Cytochrome P450 1B1 and Arachidonic Acid Metabolites;Drug Metabolism and Disposition;2024-06-05

4. 2-Methoxyestradiol ameliorates doxorubicin-induced cardiotoxicity by regulating the expression of GLUT4 and CPT-1B in female rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-04-23

5. Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids;Drug Metabolism Reviews;2023-11-21